Retrospective Cohort Study: Scope for Improvement—Barriers to Post‐Polypectomy Surveillance in the Integrated Technologies for Improved Polyp Surveillance Cohort
Alimentary Pharmacology & Therapeutics · 2025
DOI: 10.1111/apt.18514 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Charlotte Mathews und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Garscube Esta…. Hauptthemen laut MEDLINE: Colonic Polyps, Colorectal Neoplasms, Colonoscopy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovate UK.
Abstract (Originalsprache)
Background
Adherence to post‐polypectomy surveillance is poor despite evidence that it is associated with lower risk of future colorectal cancer.
Methods
We evaluated 6,210 bowel screening participants between 2009‐2016 in NHS Greater Glasgow and Clyde to assess potential barriers to post‐polypectomy surveillance.
Results
Increasing deprivation (Scottish Index of Multiple Deprivation quintile 1 vs 5; OR 1.68; p < 0.001), and increasing comorbidity (Charlson Comorbidity Index 1‐2 vs 3‐4; OR 1.80; p < 0.001, vs ≥ 5; OR 3.31; p < 0.001), were associated with non‐surveillance in British Society of Gastroenterology 2002 intermediate/high‐risk patients, while ACE‐Inhibitor (OR 0.78; p < 0.001) and aspirin use (OR 0.34; p < 0.001) were associated with undergoing surveillance. The most deprived patients receiving surveillance had more metachronous polyps (54.0% vs 49.3%) and cancer (1.1% vs 0.4%) ( p = 0.044).
Discussion
Patients from more socioeconomically deprived areas are less likely to have appropriate post‐polypectomy surveillance, and are more likely to have metachronous polyps and colorectal cancer even when they do.
Conclusion
Surveillance strategies must take into account factors including socioeconomic deprivation and comorbidity exist to improve surveillance uptake in this group through the design of targeted interventions which move away from the current “one size fits all” approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Garscube Estate, Glasgow, UK.
- Academic Unit of Surgery, Glasgow Royal Infirmary, Glasgow, UK.
- School of Health and Wellbeing, College of Medical Veterinary and Life Sciences, Glasgow, UK.
- NHS Greater Glasgow and Clyde, Research and Innovation, Queen Elizabeth University Hospital, Glasgow, UK.
ORCID-Profile: Stephen T McSorley
Förderung
- Innovate UK
Zitieren
APA
Mathews, C., Nauman, A., Johnstone, M., Stoops, R., Tham, A., Parsons, E. C., Robb, K. A., Sloan, W., Lynch, G., Edwards, J., McSorley, S. T., & INCISE collaborative group (2025). Retrospective Cohort Study: Scope for Improvement—Barriers to Post‐Polypectomy Surveillance in the Integrated Technologies for Improved Polyp Surveillance Cohort. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18514
Vancouver
Mathews C, Nauman A, Johnstone M, Stoops R, Tham A, Parsons EC, et al. Retrospective Cohort Study: Scope for Improvement—Barriers to Post‐Polypectomy Surveillance in the Integrated Technologies for Improved Polyp Surveillance Cohort. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.18514
BibTeX
@article{Mathews2025,
author = {Mathews, Charlotte and Nauman, Aleena and Johnstone, Mark and Stoops, Reiss and Tham, Alexander and Parsons, Emma C and Robb, Kathryn A and Sloan, William and Lynch, Gerard and Edwards, Joanne and McSorley, Stephen T and INCISE collaborative group, INCISE collaborative group},
title = {Retrospective Cohort Study: Scope for Improvement—Barriers to Post‐Polypectomy Surveillance in the Integrated Technologies for Improved Polyp Surveillance Cohort},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
doi = {10.1111/apt.18514}
}
EUVIMED